Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: Implications for the ACE-inhibitor-induced effects in patients with coronary artery disease

Clinical Science

Volumn 126, Issue 6, 2014, Pages 441-449

  Wu, Haiyan ^a   Roks, Anton J M ^a   Leijten, Frank P J ^a   Garrelds, Ingrid M ^a   Musterd Bhaggoe, Usha M ^a   Van den Bogaerdt, Antoon J ^a   De Maat, Moniek P M ^a   Simoons, Maarten L ^a   Jan Danser, A H ^a   Oeseburg, Hisko ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

17 oestradiol; Angiotensin converting enzyme inhibition; Bradykinin; Bradykinin B1 receptor; CXC chemokine ligand 5 (CXCL5); Human coronary artery; Mononuclear cell

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; ESTRADIOL; INTERLEUKIN 6; PERINDOPRIL;

ADULT; ALLELE; ARTICLE; CELL ACTIVATION; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DRUG EFFICACY; FEMALE; GENDER; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; YOUNG ADULT;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; CHEMOKINE CXCL5; CORONARY ARTERY DISEASE; CORONARY VESSELS; ESTRADIOL; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, BRADYKININ B1; SEX CHARACTERISTICS; SEX FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 84891387842     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130204     Document Type: Article

References (46)

1. European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362, 782-788
2. Brugts, J. J., Isaacs, A., Boersma, E., van Duijn, C. M., Uitterlinden, A. G., Remme, W., Bertrand, M., Ninomiya, T., Ceconi, C., Chalmers, J. et al. (2010) Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. Eur. Heart J. 31, 1854-1864
3. Cyr, M., Lepage, Y., Blais, Jr, C., Gervais, N., Cugno, M., Rouleau, J. L. and Adam, A. (2001) Bradykinin and des-Arg9-bradykinin metabolic pathways and kinetics of activation of human plasma. Am. J. Physiol. Heart Circ. Physiol. 281, H275-H283
4. Regoli, D. and Barabe, J. (1980) Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32, 1-46
5. Drummond, G. R. and Cocks, T. M. (1995) Endotheliumdependent relaxation to the B1 kinin receptor agonist des-Arg9-bradykinin in human coronary arteries. Br. J. Pharmacol. 116, 3083-3085
6. Drummond, G. R. and Cocks, T. M. (1995) Endothelium-dependent relaxations mediated by inducible B1 and constitutive B2 kinin receptors in the bovine isolated coronary artery. Br. J. Pharmacol. 116, 2473-2481
7. Su, J. B., Houel, R., Heloire, F., Barbe, F., Beverelli, F., Sambin, L., Castaigne, A., Berdeaux, A., Crozatier, B. and Hittinger, L. (2000) Stimulation of bradykinin B1 receptors induces vasodilation in conductance and resistance coronary vessels in conscious dogs: comparison with B2 receptor stimulation. Circulation 101, 1848-1853
8. Duchene, J., Lecomte, F., Ahmed, S., Cayla, C., Pesquero, J., Bader, M., Perretti, M. and Ahluwalia, A. (2007) A novel inflammatory pathway involved in leukocyte recruitment: role for the kinin B1 receptor and the chemokine CXCL5. J. Immunol. 179, 4849-4856
9. Modeer, T., Anduren, I. and Yucel-Lindberg, T. (1998) Bradykinin synergistically stimulates interleukin 6 production in human gingival fibroblasts challenged with interleukin 1 or tumour necrosis factor α. Cytokine 10, 26-31
10. Pesquero, J. B., Araujo, R. C., Heppenstall, P. A., Stucky, C. L., Silva, Jr, J. A., Walther, T., Oliveira, S. M., Pesquero, J. L., Paiva, A. C., Calixto, J. B. et al. (2000) Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 8140-8145
11. Angers, M., Drouin, R., Bachvarova, M., Paradis, I., Bissell, B., Hiromura, M., Usheva, A. and Bachvarov, D. (2005) In vivo DNase I-mediated footprinting analysis along the human bradykinin B1 receptor (BDKRB1) gene promoter: evidence for cell-specific regulation. Biochem. J. 389, 37-46
12. Chai, K. X., Ni, A., Wang, D., Ward, D. C., Chao, J. and Chao, L. (1996) Genomic DNA sequence, expression, and chromosomal localization of the human B1 bradykinin receptor gene BDKRB1. Genomics 31, 51-57
13. Yang, X. and Polgar, P. (1996) Genomic structure of the human bradykinin B1 receptor gene and preliminary characterization of its regulatory regions. Biochem. Biophys. Res. Commun. 222, 718-725
14. Johnson, A. D., Handsaker, R. E., Pulit, S. L., Nizzari, M. M., O'Donnell, C. J. and de Bakker, P. I. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24, 2938-2939
15. Stork, A. P. and Cocks, T. M. (1994) Pharmacological reactivity of human epicardial coronary arteries: phasic and tonic responses to vasoconstrictor agents differentiated by nifedipine. Br. J. Pharmacol. 113, 1093-1098
16. Batenburg, W. W., Jansen, P. M., van den Bogaerdt, A. J. and Danser, A. H. J. (2012) Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase. Cardiovasc. Res. 94, 136-143
17. Rompe, F., Artuc, M., Hallberg, A., Alterman, M., Stroder, K., Thone-Reineke, C., Reichenbach, A., Schacherl, J., Dahlof, B., Bader, M. et al. (2010) Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor κB. Hypertension 55, 924-931
18. Dabek, J., Wilczok, T., Gasior, Z., Kucia-Kuzma, S., Twardowski, R. and Kulach, A. (2007) Gene expression of kinin receptors B1 and B2 in PBMC from patients with cardiac syndrome X. Scand. Cardiovasc. J. 41, 391-396
19. Helske, S., Laine, M., Kupari, M., Lommi, J., Turto, H., Nurmi, L., Tikkanen, I., Werkkala, K., Lindstedt, K. A. and Kovanen, P. T. (2007) Increased expression of profibrotic neutral endopeptidase and bradykinin type 1 receptors in stenotic aortic valves. Eur. Heart J. 28, 1894-1903
20. Duchene, J., Cayla, C., Vessillier, S., Scotland, R., Yamashiro, K., Lecomte, F., Syed, I., Vo, P., Marrelli, A., Pitzalis, C. et al. (2009) Laminar shear stress regulates endothelial kinin B1 receptor expression and function: potential implication in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 29, 1757-1763
21. Batenburg, W. W., Garrelds, I. M., van Kats, J. P., Saxena, P. R. and Danser, A. H. J. (2004) Mediators of bradykinin-induced vasorelaxation in human coronary microarteries. Hypertension 43, 488-492
22. Wang, P. H., Cenedeze, M. A., Campanholle, G., Malheiros, D. M., Torres, H. A., Pesquero, J. B., Pacheco-Silva, A. and Camara, N. O. (2009) Deletion of bradykinin B1 receptor reduces renal fibrosis. Int. Immunopharmacol. 9, 653-657
23. Zhou, X., Prado, G. N., Taylor, L., Yang, X. and Polgar, P. (2000) Regulation of inducible bradykinin B1 receptor gene expression through absence of internalization and resensitization. J. Cell. Biochem. 78, 351-362
24. Aptecar, E., Lecorvoisier, P., Teiger, E., Garot, P., Dupouy, P., Sediame, S., Vermes, E., Loisance, D., Hittinger, L., Dubois-Rande, J. L. and Montagne, O. (2006) Coronary vasomotor response to the selective B1-kinin-receptor agonist des-Arg9-bradykinin in humans. J. Heart Lung Transplant. 25, 187-194
25. Duchene, J. and Ahluwalia, A. (2009) The kinin B1 receptor and inflammation: new therapeutic target for cardiovascular disease. Curr. Opin. Pharmacol. 9, 125-131
26. Paegelow, I., Werner, H. and Reissmann, S. (1995) Effects of bradykinin and bradykinin analogues on spleen cells of mice. Eur. J. Pharmacol. 279, 211-216
27. Schanstra, J. P., Bataille, E., Marin Castano, M. E., Barascud, Y., Hirtz, C., Pesquero, J. B., Pecher, C., Gauthier, F., Girolami, J. P. and Bascands, J. L. (1998) The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-κB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts. J. Clin. Invest. 101, 2080-2091
28. Knowlton, A. A. and Lee, A. R. (2012) Estrogen and the cardiovascular system. Pharmacol. Ther. 135, 54-70
29. Ritzel, R. M., Capozzi, L. A. and McCullough, L. D. (2013) Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm. Behav. 63, 238-253
30. Cutolo, M., Montagna, P., Brizzolara, R., Sulli, A., Seriolo, B., Villaggio, B., Triolo, P., Clerico, P. and Soldano, S. (2009) Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients. J. Autoimmun. 32, 254-260
31. Spencer, T. A., Chai, H., Fu, W., Ramaswami, G., Cox, M. W., Conklin, B. S., Lin, P. H., Lumsden, A. B., Yao, Q. and Chen, C. (2004) Estrogen blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J. Surg. Res. 118, 83-90
32. Cox, M. W., Fu, W., Chai, H., Paladugu, R., Lin, P. H., Lumsden, A. B., Yao, Q. and Chen, C. (2005) Effects of progesterone and estrogen on endothelial dysfunction in porcine coronary arteries. J. Surg. Res. 124, 104-111
33. Kublickiene, K., Svedas, E., Landgren, B. M., Crisby, M., Nahar, N., Nisell, H. and Poston, L. (2005) Small artery endothelial dysfunction in postmenopausal women: in vitro function, morphology, and modification by estrogen and selective estrogen receptor modulators. J. Clin. Endocrinol. Metab. 90, 6113-6122
34. Traupe, T., Stettler, C. D., Li, H., Haas, E., Bhattacharya, I., Minotti, R. and Barton, M. (2007) Distinct roles of estrogen receptors α and β mediating acute vasodilation of epicardial coronary arteries. Hypertension 49, 1364-1370
35. Rowan, M. P., Berg, K. A., Milam, S. B., Jeske, N. A., Roberts, J. L., Hargreaves, K. M. and Clarke, W. P. (2010) 17β-Estradiol rapidly enhances bradykinin signaling in primary sensory neurons in vitro and in vivo. J. Pharmacol. Exp. Ther. 335, 190-196
36. Zhang, Y., Adner, M. and Cardell, L. O. (2005) Glucocorticoids suppress transcriptional up-regulation of bradykinin receptors in a murine in vitro model of chronic airway inflammation. Clin. Exp. Allergy 35, 531-538
37. Deblois, D., Bouthillier, J. and Marceau, F. (1988) Effect of glucocorticoids, monokines and growth factors on the spontaneously developing responses of the rabbit isolated aorta to des-Arg9-bradykinin. Br. J. Pharmacol. 93, 969-977
38. Cabrini, D. A., Campos, M. M., Tratsk, K. S., Merino, V. F., Silva, Jr, J. A., Souza, G. E., Avellar, M. C., Pesquero, J. B. and Calixto, J. B. (2001) Molecular and pharmacological evidence for modulation of kinin B1 receptor expression by endogenous glucocorticoids hormones in rats. Br. J. Pharmacol. 132, 567-577
39. Kinyamu, H. K. and Archer, T. K. (2003) Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression. Mol. Cell. Biol. 23, 5867-5881
40. Genazzani, A. R., Lombardi, I., Borgioli, G., di Bono, I., Casarosa, E., Gambacciani, M., Palumbo, M., Genazzani, A. D. and Luisi, M. (2003) Adrenal function under long-term raloxifene administration. Gynecol. Endocrinol. 17, 159-168
41. Maric-Bilkan, C. and Manigrasso, M. B. (2012) Sex differences in hypertension: contribution of the renin-angiotensin system. Gend. Med. 9, 287-291
42. Seeland, U. and Regitz-Zagrosek, V. (2012) Sex and gender differences in cardiovascular drug therapy. Handb. Exp. Pharmacol. 2012, 211-236
43. Sampson, A. K., Hilliard, L. M., Moritz, K. M., Thomas, M. C., Tikellis, C., Widdop, R. E. and Denton, K. M. (2012) The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R159-R165
44. Nickenig, G., Baumer, A. T., Grohe, C., Kahlert, S., Strehlow, K., Rosenkranz, S., Stablein, A., Beckers, F., Smits, J. F., Daemen, M. J. et al. (1998) Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97, 2197-2201
45. Rabi, D. M., Khan, N., Vallee, M., Hladunewich, M. A., Tobe, S. W. and Pilote, L. (2008) Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy. Can. J. Cardiol. 24, 491-496
46. Gimenez, J., Garcia, M. P., Serna, M., Bonacasa, B., Carbonell, L. F., Quesada, T. and Hernandez, I. (2006) 17β-Oestradiol enhances the acute hypotensive effect of captopril in female ovariectomized spontaneously hypertensive rats. Exp. Physiol. 91, 715-722